Effect of Intensif Phase of Anti Tuberculosis Drug Therapy on the Quality of Life Tuberculosis Patients in Kupang City
-
Verentika Putri Tanof(1*)
Universitas Nusa Cendana
-
Ika Febianti Buntoro(2)
Universitas Nusa Cendana
-
Idawati Trisno(3)
Universitas Nusa Cendana
(*) Corresponding Author
Abstract
Background : Tuberculosis (TB) is a direct infectious disease that can attack various organs or tissues of the body caused by the Mycobacterium tuverculosis bacteria. Patients with pulmonary TB often become very weak due prolonged chronic illness, weight loss, chest pain and shortness of breath. Intensive phase of pulmonary TB treatment administered for 2 months with OAT consist of isoniazid, rifampisin, pirazinamid, and ethambutol. OAT not only cures patients and cripples BTA but also has side effects that influence patients. Clinical symptoms and OAT side effects will affect the quality of life of patients with pulmonary TB.
Objective : To knowt the influence of anti tuberculosis therapy on the quality of life of pulmonary TB patients.
Method : This study used the research design of Quasy-Experimental One Group Pretest and Post Test, to determine the quality of life of patients with pulmonary TB before and after administration of anti-tuberculosis for 2 months conducted in 11 health centers in Kupang by interview using the SF-36 questionnaire. Sampling techniques use consecutive sampling with a total of 44 samples meeting the criteria of inclusion. Research was analyzed Univariate, Bivariate using Test MC Nemar and multivariate using regression logistic multiple test.
Results: In this study the test results of MC Nemar showed the value of P = 0,000 (P < 0.05). And the test results regression logistic multiple with the value P = 0.024, which indicate there is a significant influence of intensive phase anti-tuberculosis drug therapy on the quality of life of tuberculosis patients.
Conclusion: In this study, it is known that the quality of life of pulmonary TB patients before the administration of intensive phase of anti-tuberculosis drugs is categorized low and after the administration of anti-tuberculosis drugs is categorized high.
Downloads
References
2. Wulandari A, Adi S. Faktor Risiko dan Potensi Penularan Tuberkulosis Paru di Kabupaten Kendal , Jawa Tengah. Jurnal Kesehat Lingkung Indonesia. 2015;14(1):7–13.
3. WHO. Global Tuberculosis Report. 2018;
4. Cahyanti M. Gaya hidup pasien yang mengalami tuberkulosis paru di Balai Besar Kesehatan Paru Masyarakat Surakarta. Stikes Kusuma Husada. 2016;
5. Bakri M. Evaluasi penggunaan obat antituberkulosis (oat) pada pasien tuberkulosis paru di puskesmas jumpandang baru makassar. Univ Islam Negeri Alauddin Makassar. 2016;
6. Rini V. Pengaruh pemantuan apoteker terhadap keberhasilan terapi dan kualitas hidup pasien tuberkulosis. Fakultas Farmasi Univ Gadjah Madah, Yogyakarta. 2014:185–192.
7. Perwitasari D, Mulyani U, Thobari J. Pengukuran kualitas hidup pasien tuberkulosis menggunakan instrumen st george respiratory questionnaire (sgrq) di yogyakarta. Program Pasca Sarjana Farmasi Univ Ahmad Dahlan Yogyakarta. 2015;28–34.
8. Tinartayu S, Udji B, Riyanto D. SF-36 sebagai Instrumen Penilai Kualitas Hidup Penderita Tuberkulosis ( TB ). Fakultas Kedokteran dan Ilmu Kesehatan Universitas Muhammadiyah Yogyakarta. 2009;7–14.
9. Kemenkes. Riset Kesehatan Dasar (RISKESDAS) 2018. Badan Penelit dan Pengembangan Kesehatan. 2018;
10. Muflihatin SK, Milkhatun, Hardianti. Hubungan Kepatuhan Minum Obat dengan Kualitas Hidup Pasien Tuberkulosis di Wilayah Kerja Puskesmas Segiri Samarinda. Prodi Ilmu Keperawatan, Univ Muhammadiyah Kalimantan Timur. 2018;141–51.
11. Putri JA. Hubungan Pengetahuan dan Tingkat Pendidikan PMO (Pengawas Minum Obat) Terhadap Kepatuhan Minum Obat Antituberkulosis Pasien Tb Paru. 2015;4:81–86.
Copyright (c) 2022 Cendana Medical Journal (CMJ)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Notice
This work is licensed under a Creative Commons Attribution 4.0 International License.
